1. Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain
    Emma Langella et al, 2020, Cell. Mol. Life Sci. CrossRef
  2. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
    Milad Ashrafizadeh et al, 2020, Cellular Signalling CrossRef
  3. The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors
    Nikola Geskovski et al, 2021, Beilstein J. Nanotechnol. CrossRef
  4. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
    Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
  5. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
    Mahdi Abdoli Shadbad et al, 2021, Front. Oncol. CrossRef
  6. CD44 Promotes Lung Cancer Cell Metastasis through ERK–ZEB1 Signaling
    Yen-Yun Wang et al, 2021, Cancers CrossRef
  7. The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
    Ting Guo et al, 2022, Front. Oncol. CrossRef
  8. Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
    Yue Zheng et al, 2022, Front. Oncol. CrossRef
  9. Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
    Fatéméh Dubois et al, 2022, Targ Oncol CrossRef
  10. Chitosan–Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy
    Lisa Efriani Puluhulawa et al, 2022, Polymers CrossRef
  11. Pleiotropic effects of DCLK1 in cancer and cancer stem cells
    Dibyashree Chhetri et al, 2022, Front. Mol. Biosci. CrossRef
  12. A Novel Strategy for Identifying NSCLC MicroRNA Biomarkers and Their Mechanism Analysis Based on a Brand-New CeRNA-Hub-FFL Network
    Jin Zhang et al, 2022, IJMS CrossRef